Name | Number of supported studies | Average coverage | |
---|---|---|---|
erythroblast | 3 studies | 22% ± 4% |
Insufficient scRNA-seq data for expression of CDK2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 1985.89 | 180 / 180 | 100% | 28.81 | 430 / 430 |
lung | 100% | 2875.76 | 578 / 578 | 100% | 25.88 | 1153 / 1155 |
skin | 100% | 2163.04 | 1809 / 1809 | 100% | 210.24 | 471 / 472 |
uterus | 100% | 1721.37 | 170 / 170 | 100% | 52.98 | 457 / 459 |
breast | 100% | 1845.77 | 459 / 459 | 99% | 28.21 | 1112 / 1118 |
esophagus | 100% | 1973.54 | 1445 / 1445 | 99% | 22.30 | 182 / 183 |
bladder | 100% | 1626.95 | 21 / 21 | 99% | 36.81 | 500 / 504 |
intestine | 100% | 1459.88 | 966 / 966 | 99% | 25.13 | 522 / 527 |
stomach | 100% | 1144.19 | 359 / 359 | 99% | 22.50 | 282 / 286 |
prostate | 100% | 1663.91 | 245 / 245 | 98% | 15.75 | 494 / 502 |
thymus | 100% | 1370.89 | 653 / 653 | 96% | 15.64 | 578 / 605 |
pancreas | 99% | 670.90 | 324 / 328 | 94% | 19.24 | 167 / 178 |
kidney | 100% | 1128.49 | 89 / 89 | 91% | 13.28 | 816 / 901 |
liver | 100% | 772.97 | 226 / 226 | 75% | 11.50 | 303 / 406 |
adrenal gland | 100% | 969.43 | 258 / 258 | 42% | 6.99 | 96 / 230 |
brain | 35% | 158.70 | 920 / 2642 | 71% | 13.19 | 503 / 705 |
adipose | 100% | 1620.59 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 246.19 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 31.46 | 29 / 29 |
spleen | 100% | 1808.98 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 42.42 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 23.37 | 1 / 1 |
blood vessel | 100% | 1373.04 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 786.44 | 838 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 83% | 1487.28 | 767 / 929 | 0% | 0 | 0 / 0 |
muscle | 80% | 408.41 | 642 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_0010468 | Biological process | regulation of gene expression |
GO_0006813 | Biological process | potassium ion transport |
GO_0007265 | Biological process | Ras protein signal transduction |
GO_1905784 | Biological process | regulation of anaphase-promoting complex-dependent catabolic process |
GO_0006281 | Biological process | DNA repair |
GO_0051298 | Biological process | centrosome duplication |
GO_0031453 | Biological process | positive regulation of heterochromatin formation |
GO_0007165 | Biological process | signal transduction |
GO_0051301 | Biological process | cell division |
GO_0010389 | Biological process | regulation of G2/M transition of mitotic cell cycle |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006260 | Biological process | DNA replication |
GO_0043687 | Biological process | post-translational protein modification |
GO_0006338 | Biological process | chromatin remodeling |
GO_0071732 | Biological process | cellular response to nitric oxide |
GO_0006351 | Biological process | DNA-templated transcription |
GO_0051321 | Biological process | meiotic cell cycle |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0045740 | Biological process | positive regulation of DNA replication |
GO_0007346 | Biological process | regulation of mitotic cell cycle |
GO_0043247 | Biological process | telomere maintenance in response to DNA damage |
GO_0000086 | Biological process | G2/M transition of mitotic cell cycle |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0090398 | Biological process | cellular senescence |
GO_0031571 | Biological process | mitotic G1 DNA damage checkpoint signaling |
GO_0006468 | Biological process | protein phosphorylation |
GO_0007099 | Biological process | centriole replication |
GO_0000082 | Biological process | G1/S transition of mitotic cell cycle |
GO_0032298 | Biological process | positive regulation of DNA-templated DNA replication initiation |
GO_0097124 | Cellular component | cyclin A2-CDK2 complex |
GO_0000805 | Cellular component | X chromosome |
GO_0005813 | Cellular component | centrosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005635 | Cellular component | nuclear envelope |
GO_0000307 | Cellular component | cyclin-dependent protein kinase holoenzyme complex |
GO_0097135 | Cellular component | cyclin E2-CDK2 complex |
GO_0097134 | Cellular component | cyclin E1-CDK2 complex |
GO_0000806 | Cellular component | Y chromosome |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0015030 | Cellular component | Cajal body |
GO_0000781 | Cellular component | chromosome, telomeric region |
GO_0000793 | Cellular component | condensed chromosome |
GO_0001673 | Cellular component | male germ cell nucleus |
GO_0005768 | Cellular component | endosome |
GO_0097123 | Cellular component | cyclin A1-CDK2 complex |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0097472 | Molecular function | cyclin-dependent protein kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0030332 | Molecular function | cyclin binding |
GO_0035173 | Molecular function | histone kinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0004693 | Molecular function | cyclin-dependent protein serine/threonine kinase activity |
Gene name | CDK2 |
Protein name | Cyclin dependent kinase 2 Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase) |
Synonyms | CDKN2 hCG_24992 |
Description | FUNCTION: Serine/threonine-protein kinase involved in the control of the cell cycle; essential for meiosis, but dispensable for mitosis. Phosphorylates CTNNB1, USP37, p53/TP53, NPM1, CDK7, RB1, BRCA2, MYC, NPAT, EZH2. Triggers duplication of centrosomes and DNA. Acts at the G1-S transition to promote the E2F transcriptional program and the initiation of DNA synthesis, and modulates G2 progression; controls the timing of entry into mitosis/meiosis by controlling the subsequent activation of cyclin B/CDK1 by phosphorylation, and coordinates the activation of cyclin B/CDK1 at the centrosome and in the nucleus. Crucial role in orchestrating a fine balance between cellular proliferation, cell death, and DNA repair in human embryonic stem cells (hESCs). Activity of CDK2 is maximal during S phase and G2; activated by interaction with cyclin E during the early stages of DNA synthesis to permit G1-S transition, and subsequently activated by cyclin A2 (cyclin A1 in germ cells) during the late stages of DNA replication to drive the transition from S phase to mitosis, the G2 phase. EZH2 phosphorylation promotes H3K27me3 maintenance and epigenetic gene silencing. Phosphorylates CABLES1 (By similarity). Cyclin E/CDK2 prevents oxidative stress-mediated Ras-induced senescence by phosphorylating MYC. Involved in G1-S phase DNA damage checkpoint that prevents cells with damaged DNA from initiating mitosis; regulates homologous recombination-dependent repair by phosphorylating BRCA2, this phosphorylation is low in S phase when recombination is active, but increases as cells progress towards mitosis. In response to DNA damage, double-strand break repair by homologous recombination a reduction of CDK2-mediated BRCA2 phosphorylation. Phosphorylation of RB1 disturbs its interaction with E2F1. NPM1 phosphorylation by cyclin E/CDK2 promotes its dissociates from unduplicated centrosomes, thus initiating centrosome duplication. Cyclin E/CDK2-mediated phosphorylation of NPAT at G1-S transition and until prophase stimulates the NPAT-mediated activation of histone gene transcription during S phase. Required for vitamin D-mediated growth inhibition by being itself inactivated. Involved in the nitric oxide- (NO) mediated signaling in a nitrosylation/activation-dependent manner. USP37 is activated by phosphorylation and thus triggers G1-S transition. CTNNB1 phosphorylation regulates insulin internalization. Phosphorylates FOXP3 and negatively regulates its transcriptional activity and protein stability (By similarity). Phosphorylates CDK2AP2 . Phosphorylates ERCC6 which is essential for its chromatin remodeling activity at DNA double-strand breaks . . |
Accessions | ENST00000354056.4 [P24941-2] ENST00000553376.5 G3V5T9 ENST00000555408.5 E7ESI2 ENST00000440311.6 G3V317 ENST00000555357.1 P24941 ENST00000266970.9 [P24941-1] |